Table 1.
Variables | All patients (n = 36) | Propofol group (n = 18) | Sevoflurane group (n = 18) | P value* |
---|---|---|---|---|
Age (yr) | 64.8 ± 7.6 | 66.1 ± 7.2 | 63.6 ± 7.9 | 0.339 |
Weight (kg) | 71.1 ± 8.7 | 72.3 ± 6.5 | 69.8 ± 10.6 | 0.399 |
Height (cm) | 165.8 ± 6.0 | 166.0 ± 4.0 | 165.6 ± 7.6 | 0.868 |
Body mass index (kg/m2) | 25.8 ± 2.3 | 26.1 ± 1.9 | 25.4 ± 2.7 | 0.410 |
Hypertension | 16 (44.4%) | 8 (44.4%) | 8 (44.4%) | 1.000 |
Diabetes mellitus | 4 (11.1%) | 3 (16.7%) | 1 (5.6%) | 0.289 |
Preoperative laboratory values | ||||
Hemoglobin (g/dL) | 14.2 ± 0.9 | 13.9 ± 0.9 | 14.5 ± 0.9 | 0.060 |
Albumin (g/dL) | 3.88 ± 0.24 | 3.93 ± 0.18 | 3.83 ± 0.28 | 0.211 |
Creatinine (mg/dL) | 0.90 ± 0.22 | 0.92 ± 0.28 | 0.87 ± 0.13 | 0.478 |
Operation time (min) | 147.1 ± 23.4 | 149.9 ± 20.2 | 144.2 ± 26.6 | 0.472 |
Anesthesia time (min) | 187.8 ± 22.9 | 190.6 ± 18.9 | 184.9 ± 26.6 | 0.461 |
Crystalloid amount (mL) | 1273.6 ± 318.8 | 1227.8 ± 351.1 | 1319.4 ± 285.5 | 0.396 |
Data are presented as mean ± standard deviation or as number (%)
* indicates comparison between the propofol group and the sevoflurane group